The U.S. Food and Drug Administration on Friday approved Novavax's COVID-19 vaccine, but placed additional conditions on ...

After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...

The vaccine will only be available to those at high risk from Covid—excluding those who may need it to protect a relative or ...

The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with unusual ...

The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.

Novavax (NVAX) stock in focus as the U.S. FDA approves its COVID-19 vaccine Nuvaxovid for high-risk groups in the U.S. Read ...

Novavax makes the nation’s only traditional protein-based coronavirus vaccine – and until now it had emergency authorization ...

The gravity of these decisions calls for a degree of humility on the part of an FDA leader. And that’s the rub with Vinay ...

In a news release, Guthrie, the comitteee chair, heralded the committee’s plan, (which also cuts in green energy and other ...

Tucked deep in the thousand-plus pages of the multitrillion-dollar budget bill making its way through the ...

Libraries across the United States are cutting back on e-books, audiobooks and loan programs after the Trump administration ...